Investing Strategies

January 04, 2019

Buy ($175)

Companies covered: Anadarko Petroleum Corporation (NYSE:APC), Chesapeake Energy Corporation (NYSE:CHK), Concho Resources Inc. (NYSE:CXO), Diamondback Energy, Inc. (NASDAQ:FANG), Facebook, Inc. (NASDAQ:FB), Amazon.com, Inc. (NASDAQ:AMZN), Netflix, Inc. (NASDAQ:NFLX), Alphabet Inc (NASDAQ:GOOG), Chevron Corporation (NYSE:CVX), Exxon Mobil Corporation (NYSE:XOM), Targa Resources Corp. (NYSE:TRGP), Continental Resources, Inc. (NYSE:CLR), UBS AG (NYSE:UBS), WNS (Holdings) Limited (NYSE:WNS), Oxford Immunotec Global PLC (NASDAQ:OXFD), Quest Diagnostics Incorporated (NYSE:DGX), Home Depot, Inc. (The) (NYSE:HD), Dechra Pharmaceuticals plc (LON:DPH), Silergy Corp. (TPE:6415), Wilcon Depot (PM:WLCON), Motorola Solutions, Inc. (NYSE:MSI), Xylem Inc. (NYSE:XYL), Danaher Corporation (NYSE:DHR), Siemens AG (OTCMKTS:SIEGY), Harsco Corporation (NYSE:HSC), Pentair plc. (NYSE:PNR), Bank Of New York Mellon Corporation (The) (NYSE:BK), Honeywell International Inc. (NYSE:HON), General Electric Company (NYSE:GE), Broadcom Ltd (NASDAQ:AVGO), United Parcel Service, Inc. (NYSE:UPS), Goldman Sachs Group, Inc. (The) (NYSE:GS), Apple Inc. (NASDAQ:AAPL), Invesco Ltd. (NYSE:IVZ), United Natural Foods, Inc. (NASDAQ:UNFI), Kulicke and Soffa Industries, Inc. (NASDAQ:KLIC), Tidewater Inc. (NYSE:TDW), QUALCOMM Incorporated (NASDAQ:QCOM), Celgene Corporation (NASDAQ:CELG), Amgen Inc. (NASDAQ:AMGN), Gilead Sciences, Inc. (NASDAQ:GILD), Atara Biotherapeutics, Inc. (NASDAQ:ATRA), Lockheed Martin Corporation (NYSE:LMT), FedEx Corporation (NYSE:FDX), Costco Wholesale Corporation (NASDAQ:COST), Twilio Inc (NYSE:TWLO), Freeport-McMoran, Inc. (NYSE:FCX), BHP Billiton Limited (NYSE:BHP), HollyFrontier Corporation (NYSE:HFC)